BIOMAT Database Logo BIOMAT Database Logo

Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. 1993

T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Department of Biomolecular Science, Faculty of Science, Toho University, Chiba, Japan.

Some patients with granular lymphocyte-proliferative disorders (GLPD) have been reported to have an aggressive clinical course with a poor prognosis and to be refractory to chemotherapy. In this study, expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells (PBMC) of 11 patients with GLPD was examined by staining with MRK 16, a monoclonal antibody that binds to an external epitope of P-glycoprotein, and with the dye rhodamine, a known substance to be excreted from the cells through P-glycoprotein. Among those tested, the PBMC of six of eight patients with T-cell-type GLPD as well as those of three of three patients with natural killer cell-type GLPD expressed P-glycoprotein significantly. Furthermore, PBMC of two of two patients were also poorly stained with the dye rhodamine, and the treatment of PBMC with either verapamil or quinidine, multidrug resistance-reversing agents, led to their increased staining, suggesting that these PBMC actively release chemotherapeutic agents.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders.
June 1994, Leukemia & lymphoma,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
[Expression of P-glycoprotein and multidrug resistance-associated protein in peripheral blood mononuclear cells from multidrug resistant tuberculosis patients].
July 2011, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.
December 1992, Blood,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
[Granular lymphocyte-proliferative disorders].
June 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Multidrug resistance and P-glycoprotein expression.
January 1987, Annals of the New York Academy of Sciences,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Perforin gene expression in granular lymphocyte proliferative disorders.
February 1990, Blood,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Induction of large granular lymphocyte morphology in human peripheral blood mononuclear cells.
May 1987, Journal of immunology (Baltimore, Md. : 1950),
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
P-glycoprotein function in peripheral blood mononuclear cells of myasthenia gravis patients treated with tacrolimus.
February 2007, Biological & pharmaceutical bulletin,
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
[Relationship between P-glycoprotein function in peripheral blood cells and multidrug resistance in breast carcinoma].
July 2010, Zhonghua zhong liu za zhi [Chinese journal of oncology],
T Yamamoto, and T Iwasaki, and N Watanabe, and K Oshimi, and M Naito, and T Tsuruo, and Y Kobayashi
Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells.
April 2004, Biochemical and biophysical research communications,
Copied contents to your clipboard!